Mesothelin (MSLN) is a glycosylphosphatidylinositol (GPI)-anchored cell surface protein which is overexpressed in ~85% of human pancreatic cancer cells and clinical specimens [53]. Here, MSLN is linked to familial pancreatic carcinoma.